Skip to main content
Fig. 3 | Journal of Nanobiotechnology

Fig. 3

From: Co-delivery of Gefitinib and chloroquine by chitosan nanoparticles for overcoming the drug acquired resistance

Fig. 3

Study on uptake mechanisms involved in the cellular entry of NPs. a QGY cells. ***P < 0.001, vs FITC-labeled NPs treated with chlorpromazine. ###P < 0.001, vs the chloroquine loaded FITC-labeled NPs treated with chlorpromazine. b QGY/Gefitinib cells. ***P < 0.001, FITC-labeled NPs treated with chlorpromazine. ###P < 0.001, vs the chloroquine loaded FITC-labeled NPs treated with chlorpromazine. Results were expressed as mean ± SD (n = 3)

Back to article page